LA JOLLA PHARMACEUTICAL CO Insider Trading for August 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LA JOLLA PHARMACEUTICAL CO.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in LA JOLLA PHARMACEUTICAL CO for August 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 16 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 9.43 | 99 | 934 | 99 | |
| Aug 16 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 8.02 | 99 | 794 | 78,934 | 78.8 K to 78.9 K (+0.13 %) |
| Aug 16 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 9.43 | 72 | 679 | 72 | |
| Aug 16 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 8.02 | 72 | 577 | 6,209 | 6.1 K to 6.2 K (+1.17 %) |
| Aug 16 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 9.43 | 198 | 1,867 | 198 | |
| Aug 16 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 8.02 | 198 | 1,588 | 3,419 | 3.2 K to 3.4 K (+6.15 %) |
| Aug 16 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Option Exercise | A | 9.43 | 198 | 1,867 | 198 | |
| Aug 16 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Grant | A | 8.02 | 198 | 1,588 | 2,146 | 1.9 K to 2.1 K (+10.16 %) |
| Aug 02 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 8.36 | 224 | 1,873 | 224 | |
| Aug 02 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 7.11 | 224 | 1,593 | 3,221 | 3 K to 3.2 K (+7.47 %) |
| Aug 02 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 8.36 | 80 | 669 | 80 | |
| Aug 02 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 7.11 | 80 | 569 | 6,137 | 6.1 K to 6.1 K (+1.32 %) |
| Aug 02 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Option Exercise | A | 8.36 | 224 | 1,873 | 224 | |
| Aug 02 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Grant | A | 7.11 | 224 | 1,593 | 1,948 | 1.7 K to 1.9 K (+12.99 %) |
| Aug 02 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 8.36 | 112 | 936 | 112 | |
| Aug 02 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 7.11 | 112 | 796 | 78,835 | 78.7 K to 78.8 K (+0.14 %) |